Data as of May 21
| +2.06 / +2.02%|
The 21 analysts offering 12-month price forecasts for Amgen Inc have a median target of 115.00, with a high estimate of 133.00 and a low estimate of 83.00. The median estimate represents a +10.32% increase from the last price of 104.24.
The current consensus among 28 polled investment analysts is to Hold stock in Amgen Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.